Immunostimulatory oligonucleotide multimers

Details Immunostimulatory oligonucleotide multimers Immunostimulatory oligonucleotide multimers

2005-07-01

2008-09-23

Fetterolf, Brandon J (Department: 1642)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Cancer cell or component thereof

C424S277100, C536S023100

Reexamination Certificate

active

07427405

ABSTRACT:
The invention provides an immunostimulatory nucleic acid. In certain embodiments according to this aspect of the invention, the sequence of the immunostimulatory oligonucleotide and/or immunomer is at least partially self-complementary.

REFERENCES:
patent: 5366878 (1994-11-01), Pederson et al.
patent: 5635377 (1997-06-01), Pederson et al.
patent: 5652355 (1997-07-01), Metelev et al.
patent: 5912332 (1999-06-01), Agrawal et al.
patent: 6143881 (2000-11-01), Metelev et al.
patent: 6346614 (2002-02-01), Metelev et al.
Moldoveanu et al (Vaccine 16:1216-1224, 1998).
Kuramoto et al (Jpn. J. Cancer Res. 83:1128-1131, 1992).
Krieg et al (Nature 371:546-549, 1995).
Liang et al (J. Clin. Invest. 98:1119-1129, 1996).
McCluskie and Davis (J. Immunol. 161:4463-4466, 1998).
Baral et al (Cancer Immunol. Immunother. 52(3):317-327, 2003).
Kandimalla et al (Bioconjugate Chem. 13, 966-974, 2002; Nucleic Acid Research vol. 31, No. 9, 2003).
Kandimalla et al (PNAS 100(24): 14303-14308, 2003).
Donnelly et al (Nature Medicine, 9(11):1354-1356, 2003).
DeGruijl et al, Nature Medicine, 5110: 1124-1125, 1999.
Bitton R. J. (Current Opinion in Molecular Therapeutics 611: 17-26, 2004).
Weiner (J. Leukoc. Biol. 68: 455-463, 2000).
Ballas et al (J. Immunol. 167: 4878-4886, 2001).
Agrawal et al (Trends in Molecular Medicine 8(3): 114-120, 2002).
Tokunaga et al., “Antitumor Activity of Deoxyribonucleic Acid Fraction from Mycobaterium bovis BCG. I. Isolation. Physicochemical Characterization, and Antitumor Activity”, J. Natl. Cancer Inst. 72 : 955-962(1984).
Pisetsky et al., “Stimulation of in vitro proliferation of murine lymphocytes by synthetic oligodeoxynucleotides”, Molecular Biology Reports 18: 217-221 (1993).
Krieg et al., “CpG motifs in bacterial DNA trigger direct B-cell activation”, Nature 374: 546-549 (1995).
Sato et al., “Immunostimulatory DNA Sequence Necessary for Effective Intradermal Gene Immunization”, Science 273: 352-354 (1996).
Krieg et al., “CpG Motifs in Bacterial DNA and their Immune Effects”, Annu. Rev. Immunol. 20: 709-760 (2002).
Dalpke et al., “Immunopharmacology of CpG DNA”, Biol. Chem. 383: 1491-1500 (2002).
Kandimalla et al., “Towards Optimal Design of Second-Generation Immunomodulatory Oligonucleotides”, Curr. Opin. Mol. Ther. 4(2): 122-129 (2002).
Kandimalla et al., “Immunomers-novel 3′-3′-Linked CpG Oligodeoxyribonucleotides as Potent Immunomodulatory Agents”, Nucleic Acids Res. 30: 4460-4469 (2002).
Kandimalla et al, “Secondary Structures in CpG Oligonucleotides affect Immunostimulatory Activity”, Biochem. Biophys. Res. Commun. 306: 948-953 (2003).
Remington's Pharmaceutical Sciences, 18th Edition, ed. A. Gennaro, Mack Publishing Co., Easton, PA, 1990, ISBN: 0-912734-04-3.
Burgstaller, P., et al., “Aptamers and Aptazymes: Accelerating Small Molecule Drug Discovery”, Curr Opin Drug Discov Devel. 5(5): 690-700 (2002).
Iyer R.P., et al., “3H-1,2-Benzodithiole-3-one 1,1-Dioxide as an Improved Sulfurizing Reagent in the Solid-Phase Synthesis of Oligodeoxyribonucleoside Phosphorothioates”, J. Am. Chem. Soc. 112: 1253-1254 (1990).
Zhao, Q., et al., “Effect of Different Chemically Modified Oligodeoxynucleotides on Immune Stimulation”, Biochem Pharmacol. 51: 173-182 (1996).
Branda, R.F., et al., “Immune Stimulation by an antisense oligomer complementary to the rev Gene of HIV-1”, Biochem. Pharmacol. 45(10) : 2037-2043 (1993).
Bhagat L., et al., “CpG penta- and Hexadeoxyribonucleotides as potent immunomodulatory agents”, Biochem. Biophys. Res. Commun. 300: 853-861 (2003).
Hemmi H., et al., “A Toll-Like Receptor Recognizes Bacterial DNA”, Nature 408: 740-745 (2000).
Yi A.K., et al., “Rapid Induction of Mitogen-Activated Protein Kinases by Immune Stimulatory CpG DNA”, J. Immunol. 161: 4493-4497 (1998).
Stacey, K.J., et al., “Macrophages Ingest and Are Activated by Bacterial DNA”, J. Immunol. 157: 2116-2122 (1996).
Yu D., et al., “Potent CpG Oligonucleotides Containing Phosphodiester Linkages: in vitro and in vivo immunostimulatory properties”, Biochem. Biophys. Res. Commun. 297: 83-90 (2002).

Affiliated with

Also associated with

Rating

Immunostimulatory oligonucleotide multimers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunostimulatory oligonucleotide multimers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunostimulatory oligonucleotide multimers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3965877